Immediate Impact
1 by Nobel laureates 70 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
2024 Standout
Works of Divya Sakamuri being referenced
Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
2020 Nobel
Phase I Dose-Escalation Study of Anti–CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Divya Sakamuri | 41 | 9 | 20 | 20 | 6 | 68 | |
| Tianming Cui | 34 | 4 | 30 | 27 | 8 | 88 | |
| Alexei Hernandez | 36 | 3 | 26 | 9 | 9 | 66 | |
| May Ji | 35 | 6 | 25 | 19 | 4 | 62 | |
| Yuan Chen | 52 | 24 | 11 | 13 | 5 | 86 | |
| Santina Calvacchi | 26 | 15 | 35 | 5 | 9 | 163 | |
| Haihua Fu | 38 | 7 | 33 | 8 | 7 | 77 | |
| Sarah M. Shin | 32 | 3 | 25 | 9 | 9 | 62 | |
| Lucy Lim | 32 | 18 | 24 | 43 | 7 | 111 | |
| Dongning Rao | 20 | 12 | 43 | 7 | 5 | 88 | |
| Baek‐Yeol Ryoo | 61 | 24 | 10 | 23 | 8 | 79 |
All Works
Loading papers...